+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis



Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis



Gastroenterology 141(4): 1314-22, 1322.E1-5



Proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used classes of drugs, with the former frequently coprescribed to reduce gastroduodenal injury caused by the latter. However, suppression of gastric acid secretion by PPIs is unlikely to provide any protection against the damage caused by NSAIDs in the more distal small intestine. Rats were treated with antisecretory doses of omeprazole or lanzoprazole for 9 days, with concomitant treatment with anti-inflammatory doses of naproxen or celecoxib on the final 4 days. Small intestinal damage was blindly scored, and changes in hematocrit were measured. Changes in small intestinal microflora were evaluated by denaturing gradient gel electrophoresis and reverse-transcription polymerase chain reaction. Both PPIs significantly exacerbated naproxen- and celecoxib-induced intestinal ulceration and bleeding in the rat. Omeprazole treatment did not result in mucosal injury or inflammation; however, there were marked shifts in numbers and types of enteric bacteria, including a significant reduction (∼80%) of jejunal Actinobacteria and Bifidobacteria spp. Restoration of small intestinal Actinobacteria numbers through administration of selected (Bifidobacteria enriched) commensal bacteria during treatment with omeprazole and naproxen prevented intestinal ulceration/bleeding. Colonization of germ-free mice with jejunal bacteria from PPI-treated rats increased the severity of NSAID-induced intestinal injury, as compared with mice colonized with bacteria from vehicle-treated rats. PPIs exacerbate NSAID-induced intestinal damage at least in part because of significant shifts in enteric microbial populations. Prevention or reversal of this dysbiosis may be a viable option for reducing the incidence and severity of NSAID enteropathy.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260356

Download citation: RISBibTeXText

PMID: 21745447

DOI: 10.1053/j.gastro.2011.06.075


Related references

In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion 86(2): 171-177, 2013

Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury. Rheumatology International 33(10): 2513-2521, 2014

Do Proton Pump Inhibitors Exacerbate Nonsteroidal Anti-Inflammatory Drug-Induced Small-Bowel Enteropathy?. Clinical Gastroenterology and Hepatology 14(6): 816-817, 2016

Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling. Journal of Gastroenterology (): -, 2016

Phosphodiesterase inhibitors prevent NSAID-induced small intestinal injury Lack of a role for tumour necrosis factor alpha. Gastroenterology 114(4 PART 2): A408, April 15, 1998

Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. American Journal of Physiology. Gastrointestinal and Liver Physiology 308(12): G994-1003, 2015

Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors. Drugs 69(1): 51-69, 2009

The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Research & Therapy 15 Suppl 3: S5-S5, 2014

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use. Digestion 97(2): 195-204, 2018

Pathogenesis of nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal ulceration: aggravation of NSAID-provoked small intestinal ulceration in adjuvant-induced arthritic rats. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 133(4): 203-205, 2009

Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug-Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology 14(6): 809-815.E1, 2015

Nitric oxide releasing NSAID derivatives do not cause intestinal injury or exacerbate pre-existing colitis. Gastroenterology 106(4 SUPPL ): A759, 1994

Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors. Deutsche Medizinische Wochenschrift 139(25-26): 1338-1338, 2014

Impact of compliance with proton pump inhibitors on NSAID treatment. American Journal of Managed Care 15(10): 681-688, 2010

COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?. Gastroenterology 127(4): 1256-1258, 2004